Invasive potential of melanoma cells correlates with the expression of MT1-MMP and regulated by modulating its association with motility receptors via N-glycosylation on the receptors

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ranjan, Amit ^a   Kalraiya, Rajiv D ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; BETA1 INTEGRIN; HERMES ANTIGEN; MATRIX METALLOPROTEINASE 14; MOTILITY RECEPTOR; RECEPTOR; SWAINSONINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; UROKINASE PLASMINOGEN ACTIVATION RECEPTOR; CD44 PROTEIN, MOUSE; MMP14 PROTEIN, MOUSE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL LYSATE; CELL MOTILITY; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; GLYCOSYLATION; IMMUNOPRECIPITATION; MELANOMA CELL; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL MOTION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; ANTIGENS, CD29; ANTIGENS, CD44; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; MATRIX METALLOPROTEINASE 14; MELANOMA; MICE; NEOPLASM INVASIVENESS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84907405042     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/804680     Document Type: Article

References (39)

1. W. G. Stetler-Stevenson, L. A. Liotta, and D. E. Kleiner Jr., "Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis," The FASEB Journal, vol. 7, no. 15, pp. 1434-1441, 1993.
2. V. P. Terranova, D. Maslow, and G. Markus, "Directed migration of murine and human tumor cells to collagenases and other proteases," Cancer Research, vol. 49, no. 17, pp. 4835-4841, 1989.
3. J. K. Woodward, I. Holen, R. E. Coleman, and D. J. Buttle, "The roles of proteolytic enzymes in the development of tumourinduced bone disease in breast and prostate cancer," Bone, vol. 41, no. 6, pp. 912-927, 2007.
4. S. Löffek, O. Schilling, and C.-W. Franzke, "Series "matrix metalloproteinases in lung health and disease": biological role of matrix metalloproteinases: a critical balance," European Respiratory Journal, vol. 38, no. 1, pp. 191-208, 2011.
5. A. Köhrmann, U. Kammerer, M. Kapp, J. Dietl, and J. Anacker, "Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature," BMC Cancer, vol. 9, article 188, 2009.
6. O. R. F. Mook, W. M. Frederiks, and C. J. F. van Noorden, "The role of gelatinases in colorectal cancer progression and metastasis," Biochimica et Biophysica Acta - Reviews on Cancer, vol. 1705, no. 2, pp. 69-89, 2004.
7. J. C. Huijzer, C. E. Uhlenkott, and G. G. Meadows, "Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: lack of association with in vitro invasion," International Journal of Cancer, vol. 63, no. 1, pp. 92-99, 1995.
8. B. V. V. G. Reddy and R. D. Kalraiya, "Sialilated β1,6 branched N-oligosaccharides modulate adhesion, chemotaxis and motility of melanoma cells: effect on invasion and spontaneous metastasis properties," Biochimica et Biophysica Acta, vol. 1760, no. 9, pp. 1393-1402, 2006.
9. A. Ranjan, S. M. Bane, and R. D. Kalraiya, "Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells," Experimental Cell Research, vol. 322, no. 2, pp. 249-264, 2014.
10. R. Mazzieri, L. Masiero, L. Zanetta et al., "Control of type IV collagenase activity by the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants," EMBO Journal, vol. 16, no. 9, pp. 2319-2332, 1997.
11. M. Toth, I. Chvyrkova, M. M. Bernardo, S. Hernandez-Barrantes, and R. Fridman, "Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes," Biochemical and Biophysical Research Communications, vol. 308, no. 2, pp. 386-395, 2003.
12. J. M. Coppola, M. S. Bhojani, B. D. Ross, and A. Rehemtulla, "A small molecule furin inhibitor inhibits cancer cell motility and invasiveness," Neoplasia, vol. 10, no. 4, pp. 363-370, 2008.
13. V. Krishnan, S. M. Bane, P. D. Kawle, K. N. Naresh, and R. D. Kalraiya, "Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium," Clinical and Experimental Metastasis, vol. 22, no. 1, pp. 11-24, 2005.
14. G. L. Peterson, "A simplification of the protein assay method of Lowry et al. Which is more generally applicable," Analytical Biochemistry, vol. 83, no. 2, pp. 346-356, 1977.
15. U. K. Laemmli, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4," Nature, vol. 227, no. 5259, pp. 680-685, 1970.
16. H. Towbin, T. Staehelin, and J. Gordon, "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications," Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 9, pp. 4350-4354, 1979.
17. A. Ranjan and R. D. Kalraiya, "Alpha 2, 6 Sialylation associated with increased beta 1, 6-branched N-oligosaccharides influences cellular adhesion and invasion," Journal of Biosciences, vol. 38, no. 5, pp. 867-876, 2013.
18. Q. Yu and I. Stamenkovic, "Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion," Genes and Development, vol. 13, no. 1, pp. 35-48, 1999.
19. S. Valastyan and R. A. Weinberg, "Tumor metastasis: molecular insights and evolving paradigms," Cell, vol. 147, no. 2, pp. 275-292, 2011.
20. X. Zhang, Y. Liu, M. Z. Gilcrease et al., "A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line," Cancer, vol. 95, no. 8, pp. 1663-1672, 2002.
21. M. Seiki, "Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion," Cancer Letters, vol. 194, no. 1, pp. 1-11, 2003.
22. W. Alpízar-Alpízar, I. J. Christensen, E. Santoni-Rugiu et al., "Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma," International Journal of Cancer, vol. 131, no. 4, pp. E329-E336, 2012.
23. A. Watanabe, D. Hosino, N. Koshikawa, M. Seiki, T. Suzuki, and K. Ichikawa, "Critical role of transient activity of MT1-MMP for ECM degradation in invadopodia," PLoS Computational Biology, vol. 9, no. 5, Article ID e1003086, 2013.
24. M. A. Chellaiah and T. Ma, "Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts," BioMed Research International, vol. 2013, Article ID 302392, 13 pages, 2013.
25. H. W. Smith and C. J. Marshall, "Regulation of cell signalling by uPAR," Nature Reviews Molecular Cell Biology, vol. 11, no. 1, pp. 23-36, 2010.
26. S. S. Lakka, C. S. Gondi, D. H. Dinh et al., "Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas," Journal of Biological Chemistry, vol. 280, no. 23, pp. 21882-21892, 2005.
27. A. S. Rigg and N. R. Lemoine, "Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo," Cancer Gene Therapy, vol. 8, no. 11, pp. 869-878, 2001.
28. R. Khokha, M. J. Zimmer, C. H. Graham, P. K. Lala, and P. Waterhouse, "Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells," Journal of the National Cancer Institute, vol. 84, no. 13, pp. 1017-1022, 1992.
29. S. Koop, R. Khokha, E. E. Schmidt et al., "Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth," Cancer Research, vol. 54, no. 17, pp. 4791-4797, 1994.
30. C. Tang, M. L. Hill, A. N. Brumwell, H. A. Chapman, and Y. Wei, "Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with β1 integrins," Journal of Cell Science, vol. 121, part 22, pp. 3747-3758, 2008.
31. H. Mori, T. Tomari, N. Koshikawa et al., "CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain," EMBO Journal, vol. 21, no. 15, pp. 3949-3959, 2002.
32. R. O. Hynes, "Integrins: bidirectional, allosteric signaling machines," Cell, vol. 110, no. 6, pp. 673-687, 2002.
33. R. Pili, J. Chang, R. A. Partis, R. A. Mueller, F. J. Chrest, and A. Passaniti, "The α-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth," Cancer Research, vol. 55, no. 13, pp. 2920-2926, 1995.
34. S. Lemaire, C. Derappe, J. Michalski, M. Aubery, and D. Néel, "Expression of β1-6-branched N-linked oligosaccharides is associated with activation in human T4 and T8 cell populations," Journal of Biological Chemistry, vol. 269, no. 11, pp. 8069-8074, 1994.
35. M. Tomiie, S. Isaka, E. Miyoshi et al., "Elevated expression of N-acetylglucosaminyltransferase V in first trimester human placenta," Biochemical and Biophysical Research Communications, vol. 330, no. 3, pp. 999-1004, 2005.
36. R. Takano, M. Nose, T. Nishihira, and M. Kyogoku, "Increase of β1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro," The American Journal of Pathology, vol. 137, no. 5, pp. 1007-1011, 1990.
37. S. Yagel, R. Feinmesser, C. Waghorne, P. K. Lala, M. L. Breitman, and J. W. Dennis, "Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes," International Journal of Cancer, vol. 44, no. 4, pp. 685-690, 1989.
38. H. Yamamoto, J. Swoger, S. Greene et al., "β1,6-N-acethylglucosamine-bearing N-glycans in human gliomas: Implications for a role in regulating invasivity," Cancer Research, vol. 60, no. 1, pp. 134-142, 2000.
39. M. E. Janik, M. Przybylo, E. Pochec, M. Pokrywka, and A. Litynska, "Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin," Acta Biochimica Polonica, vol. 57, no. 1, pp. 55-61, 2010.